Handelsbanken Fonder’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $705K | Buy |
24,500
+2,700
| +12% | +$77.7K | ﹤0.01% | 1104 |
|
|
2025
Q1 | $731K | Hold |
21,800
| – | – | ﹤0.01% | 1074 |
|
|
2024
Q4 | $1.12M | Buy |
21,800
+2,800
| +15% | +$143K | ﹤0.01% | 922 |
|
|
2024
Q3 | $971K | Buy |
19,000
+2,600
| +16% | +$133K | ﹤0.01% | 956 |
|
|
2024
Q2 | $735K | Buy |
16,400
+3,100
| +23% | +$139K | ﹤0.01% | 982 |
|
|
2024
Q1 | $623K | Buy |
13,300
+800
| +6% | +$37.5K | ﹤0.01% | 1064 |
|
|
2023
Q4 | $445K | Buy |
+12,500
| New | +$445K | ﹤0.01% | 1205 |
|